study of Oxytocin versus Carbetocin for the prevention of primary post partum hemorrhage following caesarean delivery in pregnant women

A comparative study between Oxytocin and Carbetocin for the prevention of primary postpartum hemorrhage following caesarean delivery. - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/04/065815

Enrollment

100

Registered

2024-04-16

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O80-O82- Encounter for delivery

Interventions

Intervention1: carbetocin: carbetocin 100mcg bolus given via intravenous route Control Intervention1: oxytocin: therapeutic drug intervention,comparator agent oxytocin 20 IU in 1000ml NS being compare

Eligibility

Inclusion criteria

Inclusion criteria: female with singleton, fullterm pregnancy undergoing elective or emergency caesarean section,

Exclusion criteria

Exclusion criteria: Hypersensitivity to study drugs, Cases of coagulopathy,uterine fibroid,suspected placental pathology, Medical diseases such as hypertension,diabetes mellitus,Cardiac ,renal,liver disorders .

Design outcomes

Primary

Measure	Time frame
Evaluation of hemodynamic effects of carbetocin in terms of blood loss.Timepoint: 24 hours after ceserean section	—

Secondary

Measure	Time frame
1.Need of additional uterotonics 2.Need of blood transfusion to compensate the blood loss. 3.The adverse effects encountered by the participants.Timepoint: 24 hours after ceserean section	—

Countries

India

Contacts

Public ContactAdhi lakshmi

North Bengal Medical College and Hospital

dr.sandipsengupta@gmail.com6303594367

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026